Glycation, oxidation, and browning of proteins have all been implicated in the development of diabetic complications. We measured the initial Amadori adduct, fructoselysine (FL); two Maillard products, NE-(carboxymethyl) lysine (CML) and pentosidine; and fluorescence (excitation = 328 nm, emission = 378 nm) in skin collagen from 39 type 1 diabetic patients (aged 41.5±15.3 117-731 yr; duration of diabetes 17.9±11.5
10-461 yr, Imean±SD, rangel). The measurements were related to the presence of background (n = 9) or proliferative (n = 16) retinopathy; early nephropathy (24-h albumin excretion rate IAER241 > 20 Ag/min; n = 9); and limited joint mobility (LJM; n = 20). FL, CML, pentosidine, and fluorescence increased progressively across diabetic retinopathy (P < 0.05, P < 0.001, P < 0.05, P < 0.01, respectively). FL, CML, pentosidine, and fluorescence were also elevated in patients with early nephropathy (P < 0.05, P < 0.001, P < 0.01, P < 0.01, respectively). There was no association with LJM. Controlling for age, sex, and duration of diabetes using logistic regression, FL and CML were independently associated with retinopathy (FL odds ratio (OR) = 1.06, 95% confidence interval (CI) = 1.01-1.12, P < 0.05; CML OR = 6.77, 95% CI = 1.33-34.56, P < 0.05) and with early nephropathy (FL OR = 1.05, 95% CI = 1.01-1.10, P < 0.05; CML OR = 13.44, 95% CI = 2.00-93.30, P < 0.01). The associations between fluorescence and retinopathy and between pentosidine and nephropathy approached significance (P = 0.05). These data show that FL and Maillard products in skin correlate with functional abnormalities in other tissues and suggest that protein glycation and oxidation (glycoxidation) may be implicated in the development of diabetic retinopathy and early nephropathy. (J. Clin. Invest. 1993 . 91:2470-2478.) Key words: collagen * complications of diabetes * glycation * oxidation -nonenzymatic browning Received for publication 11 May 1992 and in revisedform 2 December 1992.
A central issue in current diabetes research concerns the pathogenesis of diabetic complications (1) (2) (3) (4) (5) (6) (7) , and in particular, the role of hyperglycemia in their development (8) . Despite the problems involved in obtaining a satisfactory index of longterm blood glucose control, many clinical and epidemiological studies have supported an association between glycemic control and complications (9) (10) (11) (12) (13) (14) (15) (16) (17) . Glycation (nonenzymatic glycosylation), a ubiquitous chemical modification of proteins exposed to reducing sugars, provides the basis for an attractive hypothesis to explain this association. This hypothesis states that the biochemical, structural and functional consequences ofincreased protein glycation contribute to the development of complications.
Collagen is a long-lived protein found throughout the body. With advancing age, it undergoes marked physicochemical changes, including decreased solubility, elasticity, and sensitivity to protease digestion (18) , and increased thermal stability (19, 20) . These changes are accelerated in diabetic patients (21) , whose collagen contains significantly increased quantities of the initial product of glycation, fructoselysine (FL)' (22) . However, there is little evidence to date that FL is directly implicated in the altered properties ofcollagen. The FL content of skin collagen increases only slightly with age in nondiabetic individuals (22, 23) , and although elevated in diabetes, it is unrelated to age or duration of diabetes (22) . In existing studies, collagen FL has not been associated with the presence or severity of diabetic complications (24, 25) , and even in patients with long-standing diabetes, its concentration in collagen falls promptly with improved glycemic control (26) . In vitro, short-term glycation ofcollagen does not increase its resistance to enzymatic digestion (27) .
FL may, however, be indirectly linked with the altered properties of collagen in both aging and diabetes. In long-lived proteins, FL undergoes further dehydration, rearrangement, and cleavage reactions, which comprise the later stages ofthe Maillard reaction (28) (29) (30) . Many of these reactions involve oxidative processes, and their products, whose formation (in contrast to that of FL) is irreversible (26) , have recently been termed "glycoxidation products" (6) . Oxidation may therefore be regarded as a "fixative" ofglycative damage to proteins. The intimate interrelationship between glycation and oxida-tion is further emphasized by the observation that increased glycation may, in itself, promote the formation of free radicals and therefore enhance oxidative damage to proteins and lipids (31) . In collagen, glycoxidation products are insoluble, frequently pigmented or fluorescent, and include glucose-derived cross-links (6). They accumulate with advancing age (22, 23, 32) , and at an accelerated rate in diabetes (22, (32) (33) (34) (35) (36) , paralleling the physicochemical alterations described above. In vitro, glycoxidation of collagen causes the physicochemical alterations characteristic ofaging (34, 37) . Thus, the accumulation of late Maillard or glycoxidation products may contribute significantly to the altered physical properties of collagen in both aging and diabetes (21, 33, 34, 36) , and to the development of diabetic complications (32, (38) (39) (40) (41) (42) (43) (44) .
In this and the accompanying study (22) , FL, two glycoxidation products, NE-(carboxymethyl) lysine (CML) (23, (45) (46) (47) and pentosidine (32, (48) (49) (50) (51) , and Maillard-type fluorescence have been measured in skin collagen from type 1 diabetic patients. The accumulation of CML, pentosidine, and fluorescence throughout life, and their accelerated accumulation in diabetes, have been described in the preceding article (22) . Here we relate the levels of FL, CML, pentosidine, and collagen-linked fluorescence, corrected for age, to the presence and severity of diabetic microvascular complications. We found significant associations between all four products and complication status. Because the levels of glycoxidation products, rather than FL, seem to determine the altered properties of collagen, our data suggest that "fixation" of initial glycative damage by free radical oxidation reactions may be implicated in the link between glycemic control and diabetic complications. Thus, in diabetic patients, individual variations in oxidative stress may modulate the consequences of hyperglycemia, and explain, in part, why the relationship between glycemic control and complications is not a simple one.
Methods
Patients. 39 patients (27 male/ 12 female) were recruited from the diabetes clinics ofthe Royal Victoria Hospital, Belfast, and Altnagelvin Hospital, Londonderry, Northern Ireland. All had type I (insulin-dependent) diabetes, diagnosed according to the criteria of the National Diabetes Data Group (52). Their mean age was 41 (20 ,gg/min < AER24 < 200 .Lg/min) and "macroalbuminuric" (AER24 2 200 ,g/min) groups was made using the 24-h urine sample, the classification was confirmed by the overnight sample in all patients in whom both urine collections were available. Any patient with a suspected or proven urinary tract infection had urinary albumin estimation deferred until urine culture was negative. Urinary albumin concentration was measured by 125I radioimmunoassay involving double separation of bound and free antigen (Diagnostic Products Ltd., Wallingford, Oxfordshire, UK). The inter-and intraassay coefficients of variation were 7% and 5%, respectively, detection limit 0.9 gg/ml.
Complication status. 14 patients had no retinopathy, 9 had background retinopathy, and 16 had proliferative retinopathy. Of (22) . Measurements of collagen FL, CML, pentosidine, and collagen-linked fluorescence are also described briefly in the accompanying article (22) , and in detail elsewhere (23, (45) (46) (47) . Laboratory analyses of the collagen samples were performed without prior knowledge of sample identity. The correlations between collagen FL and HbA, and between FL and MHbA1 were highly significant (r = 0.74 and r = 0.89, respectively (P < 0.0001 )), confirming previous findings (24, 25 Data are given as means± I SD (range); NS, P > 0.05. P statistical analysis is performed using Kruskall-Wallis one-way analysis of variance. Superscript "R" denotes age-corrected ratio. * P < 0.05 compared to any retinopathy; $ P < 0.01 compared to any retinopathy; I P < 0.001 compared to any retinopathy; 11 P < 0.05 compared to no retinopathy; 1 P < 0.05 compared to no retinopathy; ** P < 0.01 compared to no retinopathy; $$ P < 0.001 compared to no retinopathy; " P < 0.05 compared to grade I retinopathy.
logistic regression analysis (56) was used to test several models of the association ofa specific complication with the Maillard products, controlling for age, sex, and duration ofdiabetes. For descriptive purposes in tables and text, the arithmetic mean± 1 SD is quoted. The conventional level of significance (P < 0.05) has been used in all analyses. Measurements ofcollagen FL, CML, pentosidine, and fluorescence were corrected for the recognized increase with age (22, 23) by expressing the observed value as a ratio of the predicted value for a control patient ofthe same age (derived from the corresponding regression line in the control population [22] ). These calculated ratios are denoted by the superscript "R" (e.g., CMLR). As the concentration of FL rises rapidly in early life, but is only weakly related to age after age 20 yr, the regression line for FL was estimated from the data for nondiabetic control subjects between the ages of20 and 85 yr. In some cases( < 10% of samples) insufficient collagen was available for all assays to be performed. Consequently, there is some variation in the number of measurements between analyses.
Results
The mean age, duration ofdiabetes, HbA,, MHbA,, and levels of each of the Maillard products across the various grades of retinopathy, nephropathy, and limited joint mobility are shown in Tables I-III and Fig. 1-3 .
Patients in the three retinopathy categories did not differ significantly in age whether considered collectively (by analysis of variance) or between subgroups (Table I ). The severity of retinopathy was related to the duration ofdiabetes (P < 0.01 ). There was no association between HbA, or MHbA1 values and retinopathy status. In contrast, age-corrected levels of skin collagen FL, CML, pentosidine, and Maillard-type fluorescence all increased progressively and significantly with the severity of retinopathy (Table I, Fig. 1 ). These increases were most significant for CML (P < 0.001 ) and for collagen-linked fluorescence (P<0.0l).
Compared with normoalbuminuric patients, patients with AER2' 2 20 ,og/min were ofslightly greater age and duration of diabetes, and their HbAI, MHbA,, and collagen FL content also tended to be higher: however, none of these differences reached significance (Table II) . In contrast, age-corrected levels of skin collagen FL, CML, pentosidine, and fluorescence were significantly higher in patients with AER24 2 20 ,gg/min than in normoalbuminuric patients (Table II, Fig. 2 ). If data for the three macroalbuminuric patients were excluded from these analyses, age-corrected CML, pentosidine, and fluorescence remained significantly elevated in microalbuminuric compared with normoalbuminuric patients (P < 0.05, P < 0.05, P < 0.01, respectively), but the difference in FL levels was no longer statistically significant. When AER24 results from all patients were analyzed together using the nonparametric Spearman correlation coefficient, there were significant correlations between AER24 and MHbA,, FLR, CMLR, pentosidineR, and fluorescence R (Table IV) . Exclusion of the three macroalbuminuric patients from these analyses decreased the correlations between AER24 and glycoxidation products (CMLR, r = 0.33; pentosidineR, r = 0.38; fluorescence R, r = 0.38 (all P = 0.06)), and MHbA,, and only the correlation between AER24 and FLR remained significant (r = 0.44, P < 0.05). If patients with micro-and macroalbuminuria were considered together as a separate group (n = 9), none of the glycation products correlated significantly with AER24. Patients with LJM (Table III) had a longer duration of diabetes than those without (P < 0.01) (also significant between grade 0 and grade 2 LJM, P < 0.01, and grade 1 and 2 LJM, P < 0.05). HbA1, MHbA,, and age-corrected collagen FL values were similar between these categories. Age-corrected CML, pentosidine, and Maillard-type fluorescence tended to increase with more severe UM (Table III, Fig. 3 ) but this was significant only for pentosidine and fluorescence, and only between patients with grade 0 and grade 2 disease (P < 0.05). In these analyses (unlike the logistic regression models described below), the Maillard products were not corrected for duration of diabetes: the observation that age-adjusted pentosidine and fluorescence showed the greatest correlations with duration of diabetes (22) may be pertinent to these findings.
CML, pentosidine, and fluorescence correlated with systolic blood pressure, but no significant association was found after the products were corrected for age. There was a significant correlation between age-corrected CML and the brachialankle systolic index (r = -0.51, P = 0.05), but this was not observed with pentosidine or fluorescence. None of the products, after correction for age, correlated with measurements of either ankle or toe vibration perception threshold.
The effect of each of the Maillard products on a specific complication of diabetes was examined using logistic regression analysis. For each complication (defined as either present or absent), serial models were examined containing a Maillard product while simultaneously controlling for age, sex, and duration ofdiabetes (Tables V and VI) . The unavailability ofsome data points, particularly for pentosidine and fluorescence, decreased the power of their respective models. The addition of either HbA1 or MHbA1 made no further contribution to any model, and so neither was included in the analyses. Skin collagen FL and CML were significant independent variables associated with the presence of retinopathy (Table  V) . A 20% increment in FL or CML was associated with an increased odds ofretinopathy (FL odds ratio (OR) = 1.06, 95% confidence interval (CI) 1.01-1.12, P < 0.05; CML OR = 6.77; 95% CI 1.33-34.56, P < 0.05). In smaller models, similarly controlling for age, sex, and duration of diabetes, neither pentosidine nor fluorescence was associated with retinopathy, although fluorescence approached significance: for a 20% increment in fluorescence the OR was 2.37 (95%CI 0.98-5.20), P = 0.05.
Skin collagen FL and CML were also significant independent variables associated with the presence of early nephropathy (AER24 2 20 ,g/min) (Table VI) . A 20% increment in FL or CML was associated with an increased odds of early nephropathy (FL OR = 1.05, 95%CI 1.0 1-1.10, P < 0.05; CML OR = 13.44, 95%CI 2.00-93.30, P < 0.01). Pentosidine approached significance as an independent variable associated with early nephropathy (OR = 1.11, 95% CI 1.00-1.23, P = 0.05). Ifthe three macroalbuminuric patients were excluded from the analyses, only CML emerged as a significant independent variable associated with microalbuminuria (OR = 9.70, 
Discussion
Several studies have reported a link between Maillard reaction products in collagen and the complications of diabetes (32, (41) (42) (43) (44) 49) . In some, levels ofdiscrete products (32, 42, 43, 49) were related to a single complication (42, 43, 49) ; in others, the conclusions were inferred from analyses of measurements of collagen-linked fluorescence (41, 44) . It is now recognized that nonglycation products, such as those derived from lipid peroxidation, have similar fluorescence spectra to carbohydrate-derived Maillard products. Because these nonglycation compounds may become covalently bound to collagen, they may contribute to total collagen fluorescence (44, 57, 58) . A strength ofthe present study is the focus on structurally characterized products ofthe Maillard reaction which have been identified in glycated proteins both in vitro and in vivo.
As summarized in Figs. 1-3 , both early (FL) and late (CML, pentosidine, and fluorescence) Maillard products in skin collagen increased with the presence and severity of dia-'betic retinopathy. In each case there was a significant increase between patients with grade 0 and grade 2 retinopathy, and for CML between grade 0 and grade 1, and between grade 1 and grade 2, disease. These and other data discussed below are consistent with a pathophysiological role for glycation and glycoxidation of proteins in diabetic retinopathy, and suggest that the extent of modification of collagen in skin may be indicative of the level of damage in other tissues, including perhaps, retinal capillary basement membrane proteins. In accordance with our findings, an increase in age-adjusted skin collagen pentosidine levels with increasing severity of retinopathy was recently reported by Sell et al. (32) . The relevance of age and duration of diabetes both to the development of complications and to the levels of glycoxidation products in skin collagen is evident in the present study and the preceding article (22) . Controlling for these variables, both skin collagen FL and CML content remained independently associated with retinopathy, and the association offluorescence with retinopathy approached significance (P = 0.05) ( Table V) . Unavailable patient data and the stronger correlation of pentosidine than the other products with duration of diabetes (22) Another new, and potentially important finding is the increase in concentrations of age-corrected FL, CML, pentosidine, and Maillard-type fluorescence in skin collagen from patients with early nephropathy compared with those who had normal albumin excretion. For the glycoxidation products and fluorescence, these increases remained significant when the microalbuminuric patients alone were compared with those who had normal albumin excretion. Using a less stringent definition of nephropathy (daily protein excretion > 0.5 g), Monnier, Sell, and co-workers have previously described trends towards increased skin collagen pentosidine (32) and fluorescence (41 ) in nephropathic compared to nonnephropathic diabetic patients, but the differences were not statistically significant. In the present study, both early and late glycation products, and MHbA1, correlated with AER24 in the entire patient group (Table IV) . The lack ofcorrelation between these products and AER24 in the nine patients whose AER24 exceeded 20 Ag/min is of uncertain significance, inasmuch as there is little power to show an effect in such a small number of patients. Controlling for age and duration ofdiabetes using logistic regression analyses, FL and CML were independently associated with the presence of nephropathy, and pentosidine approached significance (P = 0.05) (Table VI) . These findings suggest that if the accumulation ofglycation and glycoxidation products in skin collagen is reflected in renal tissue proteins, then these modifications may be relevant to the earliest stages ofdiabetic nephropathy. Putatively, modification of glomerular basement membranes could contribute to altered permeability, initially through charge-dependent mechanisms such as a decrease in anionic proteoglycans and immobilization of plasma proteins, later progressing to permanent structural damage and alteration of pore size (40) . Also, the ability of advanced Maillard products to quench the vasodilator (59) and antiproliferative (60) (49) found no increase in pentosidine in skin collagen from nonnephropathic type 2 (non-insulin-dependent) diabetic patients compared with nondiabetic control subjects. However, in a more recent study (32) , they reported increased pentosidine levels (more than twofold) in nonnephropathic type 1 (insulin-dependent) diabetic patients compared with control subjects. Our findings, in agreement with the latter study, suggest that the increase in pentosidine (and other Maillard products) is a characteristic of the diabetic population in general, and is not confined to patients with renal disease.
The significance of limitation of joint mobility in diabetes remains unclear. In the present study, there was a tendency for the Maillard products to increase with the severity of LJM, but the increase was significant only for age-corrected pentosidine and fluorescence and only between grades 0 and 2 LJM. Sell, Monnier, and co-workers also found significant associations between both pentosidine (32) and fluorescence (41) and the presence of LJM. However, in our study, by using logistic regression analysis to control for duration of diabetes, no significant associations between Maillard products and LJM remained, and in previous (unpublished) findings, we were unable to find a correlation between LJM and long-term glycemic control (serial HbA, measurements over a 6-yr period). In the present study, neurologic function, as evidenced by measurements of ankle and toe vibration perception threshold, was unrelated to levels of Maillard products in skin collagen. This is consistent with the thesis that other processes, such as osmotic effects from increased sorbitol pathway activity, may be of greater relevance than protein glycoxidation to the development of diabetic neuropathy.
Although correlations were found between levels of Maillard products and arterial blood pressure, these did not persist after correction for age. Unlike Monnier et al. (41 ), we found no association of blood pressure with severity of retinopathy, nor with the presence of early nephropathy. Age-corrected CML was weakly associated with the brachial-ankle systolic index. A related finding by Monnier et al. (41) , correlating collagen-linked fluorescence and arterial stiffness, supports the conclusion that widespread collagen browning may be implicated in the development of diabetic macrovascular disease.
It is acknowledged that with the small number ofpatients in the present study, the results oflogistic regression analysis must be interpreted with caution. However, when considered together with the significant mean differences across the various complication subgroups, the findings are consistent with a role for glycation and glycoxidation of proteins in the development of the microvascular complications of diabetes. The independent association of skin collagen FL with diabetic retinopathy and early nephropathy may imply a direct pathogenic role for glycated structural proteins in the affected tissues. However, any explanation must take into account the fact that FL levels in collagen rise rapidly after the onset of diabetes and that the increase is reversible with short-term improvements in glycemic control (26) . In contrast, complications develop only slowly over a period of years. Alternative explanations for the association between increased collagen FL and the development of complications include the possibility that chronic hyperglycemia leads to both consequences through entirely separate mechanisms, or, as we suggest, that the link may be indirect, inasmuch as in addition to glycation, oxidation is necessary to produce permanent alterations to proteins (37) . The latter hypothesis is supported by studies using aminoguanidine, which does not influence FL formation, but which inhibits collagen cross-linking in vivo (61 ) and the formation of CML and pentosidine in vitro (Fu et al., manuscript in preparation). In animal models, aminoguanidine has been shown to retard the development ofdiabetic retinopathy (62), nephropathy (63) , and neuropathy (64) .
As with collagen FL, the finding of increased concentrations of glycoxidation products in association with diabetic complications does not prove a causal relationship. Glycoxidation may be only one of perhaps several, possibly interrelated mechanisms (65) altering the properties not just of collagen, but also of other extracellular matrix constituents: abnormalities ofprotein synthesis, hydroxylation and turnover have been described (66) (67) (68) . The pathophysiological relevance of glycoxidation products in diabetes is also controversial on quantitative grounds. CML and pentosidine are present in little more than trace amounts in collagen. Despite this, they may be regarded as biomarkers of total glycoxidative damage (6), most ofwhich results in the formation ofother products whose chemical structures are, as of now, uncharacterized.
If the accumulation of glycoxidation products does indeed contribute to the development of diabetic complications, then the ability ofan individual to resist oxidative stress may modulate the consequences of hyperglycemia. Prospective studies are needed to determine whether those diabetic patients who accumulate glycoxidation products unusually rapidly (controlling for long-term glycemia), i.e., subjects with the weakest antioxidant defense mechanisms, represent a subgroup which is particularly vulnerable to the development ofcomplications. In the future, inhibition not only of glycation (by improved glycemic control), but also of oxidative stress (by dietary and pharmacologic manipulations), may offer a logical approach to the prevention of diabetic complications.
